To accelerate evelopment of molecular targeted systemic radiotherapy (SR, PRRT) based on its clinical stage technology Edinburgh, United Kingdom – 17 December 2019 – Edinburgh Molecular Imaging Ltd, a company developing theragnostic agents targeting cancer, today announces the closing of a...
Press Releases
Filter news by category :
Edinburgh Molecular Imaging Appoints Bernhard Sixt as new Chief Executive Officer
08 Nov 2018 | Corporate, Press Releases
Seasoned CEO with 30 years’ experience in the healthcare industry Edinburgh, United Kingdom - 8 November 2018 – Edinburgh Molecular Imaging (EM Imaging), the optical molecular imaging company, today announces the appointment of Dr Bernhard Sixt as Chief Executive Officer, effective immediately....
Edinburgh Molecular Imaging Ltd Appoints New Chairman
29 Oct 2018 | Corporate, Press Releases
EDINBURGH, Scotland, October 29, 2018 - Roy Davis appointed as Non-Executive Chairman - Current Chair John Jeans to continue as Non-Executive Director Edinburgh Molecular Imaging Ltd (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces the...
Edinburgh Molecular Imaging are part of a EPSRC funded consortium
19 Sep 2016 | Collaborations, Press Releases
Edinburgh Molecular Imaging is part of an EPSRC funded consortium, led by Dr Jon Shephard of Heriot-Watt University in collaboration with Professor David Jayne from the University of Leeds to develop a revolutionary new bowel cancer surgery tool that will enable surgeons to carry out operations...
Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration
07 Apr 2016 | Collaborations, Press Releases
Edinburgh and Paris, April 6th, 2016 – Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical research collaboration to study the potential of combining EM Imaging’s in vivo optical imaging agents and Mauna Kea's...
EM Imaging obtains global licence for optical agent that detects cancer early
16 Sep 2015 | Press Releases
Edinburgh, United Kingdom, 16 th September, 2015 - Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could improve the detection of early-stage colorectal (bowel) cancer. EM Imaging, a company which develops and...
Edinburgh Molecular Imaging Ltd appoints new Chairman
02 Sep 2015 | Press Releases
Edinburgh, United Kingdom, 2nd September 2015 - The Board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans CBE CEng as non-executive Chairman with effect from 31st August 2015. In an industrial career spanning 35 years John held senior...